The incidence of inhibitor development according to specific mutations--and treatment?
about
Haemophilia management: time to get personal?HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P.Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIIICellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatmentInhibitors of factor VIII in black patients with hemophiliaEvidence supporting the use of recombinant activated factor VII in congenital bleeding disorders.Plasma-derived versus recombinant Factor VIII concentrates for the treatment of haemophilia A: recombinant is better.T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.Late immune tolerance induction in haemophilia A patients.Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A.
P2860
Q30403530-7A37C5DC-F612-4AC9-918A-D0C5AF09ACE3Q33910694-E40F8C64-2BFF-4A3F-928A-C384CED0272AQ34550081-465489D8-C6E7-4397-AAFB-50AA2933B01DQ36230842-95BCECDB-EE60-40B2-8B9D-2920B4CE9109Q36338254-DB0650C4-3674-4579-9E10-B7B0616C0747Q37385316-8124D922-90DB-4FCD-83E4-F5688F52BC1CQ37778291-89BABBA8-8E67-48CE-999B-2AA6A233FD97Q41917020-8D6A1E1A-339D-4D51-9D86-2BC3E7494C44Q42381250-16B9116D-2220-470D-9B08-D1B12AE49AF4Q44853253-FF1E3EE4-695C-4900-AF62-F28EBB15B12AQ45865800-BD08AEE0-D3C4-4D05-A9E1-461C8FC3D5C9
P2860
The incidence of inhibitor development according to specific mutations--and treatment?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The incidence of inhibitor development according to specific mutations--and treatment?
@ast
The incidence of inhibitor development according to specific mutations--and treatment?
@en
type
label
The incidence of inhibitor development according to specific mutations--and treatment?
@ast
The incidence of inhibitor development according to specific mutations--and treatment?
@en
prefLabel
The incidence of inhibitor development according to specific mutations--and treatment?
@ast
The incidence of inhibitor development according to specific mutations--and treatment?
@en
P1476
The incidence of inhibitor development according to specific mutations--and treatment?
@en
P304
P356
10.1097/00001721-200306001-00005
P478
14 Suppl 1
P577
2003-06-01T00:00:00Z